Nexalin Technology (NXL) Gross Profit (2021 - 2026)

Nexalin Technology (NXL) recorded quarterly Gross Profit of $13133.0 in Q1 2026, down 91.29% quarter-over-quarter from $150866.0 in Q4 2025, and down 52.17% on a YoY basis from $27457.0 in Q1 2025.

Nexalin Technology (NXL) Gross Profit (2021 - 2026) Analysis & Trends

Nexalin Technology's Gross Profit history runs 6 years deep, the most recent figure standing at $13133.0 for Q1 2026.

  • In Q1 2026, Gross Profit fell 52.17% year-over-year to $13133.0; the TTM figure through Mar 2026 stood at $225950.0 (up 150.86% YoY), while the FY2025 annual figure was $240274.0, up 81.85% from the prior year.
  • Gross Profit was $13133.0 for Q1 2026 at Nexalin Technology, down from $150866.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $358025.0 in Q3 2022 to a low of $13133.0 in Q1 2026.
  • Historically, Gross Profit has averaged $84043.6 across 5 years, with a median of $26166.0 in 2023.
  • The sharpest annual moves came in 2022 and 2023: Gross Profit soared 667.24% in 2022, then slumped 94.37% in 2023.
  • A 5-year view of Gross Profit shows it stood at $31557.0 in 2022, then plunged by 51.5% to $15305.0 in 2023, then gained by 28.61% to $19683.0 in 2024, then jumped by 666.48% to $150866.0 in 2025, then tumbled by 91.29% to $13133.0 in 2026.
  • The last three Gross Profit figures came in at $13133.0 (Q1 2026), $150866.0 (Q4 2025), and $14201.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Nexalin Technology 7.82 Mn 5.11 Mn 13,133.00

Historic Data

Download Data
DateValue
Mar 31, 2026 13,133.00
Mar 31, 2026 13,133.00
Dec 31, 2025 150,866.00
Dec 31, 2025 150,866.00
Sep 30, 2025 14,201.00
Sep 30, 2025 14,201.00
Jun 30, 2025 47,750.00
Jun 30, 2025 47,750.00
Mar 31, 2025 27,457.00
Mar 31, 2025 27,457.00
Dec 31, 2024 19,683.00
Dec 31, 2024 19,683.00
Sep 30, 2024 23,337.00
Sep 30, 2024 23,337.00
Jun 30, 2024 19,593.00
Jun 30, 2024 19,593.00
Mar 31, 2024 69,515.00
Mar 31, 2024 69,515.00
Dec 31, 2023 15,305.00
Dec 31, 2023 15,305.00